Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples